Enlivex changes corporate name to Enlivex Ltd.
Enlivex Therapeutics Ltd. has formally changed its corporate name to Enlivex Ltd. following shareholder approval at an Extraordinary General Meeting held on February 3, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Enlivex Therapeutics Ltd. has formally changed its corporate name to Enlivex Ltd. following shareholder approval at an Extraordinary General Meeting held on February 3, 2026. Shareholders authorized the new name or another name containing the word “Enlivex,” subject to approval by the Israeli Registrar of Companies.
On February 10, 2026, the Registrar of Companies in Israel issued a Certificate of Change of Name, confirming the change to Enlivex Ltd. This certificate is attached as Exhibit 99.1 and the updated name is now incorporated by reference into the company’s existing U.S. registration statements on Forms S-8 and F-3.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What corporate change did Enlivex (ENLV) report in its latest Form 6-K?
When did Enlivex Ltd. receive official confirmation of its new name in Israel?
How does Enlivex’s (ENLV) name change affect its U.S. registration statements?
What document evidences the Enlivex (ENLV) name change in the Form 6-K filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of: February 2026
Commission file number: 001-36578
ENLIVEX LTD.
(Translation of registrant’s name into English)
14 Einstein Street, Nes Ziona, Israel 7403618
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Change of Company’s Name
On February 3, 2026, Enlivex Therapeutics Ltd., a company organized under the laws of the State of Israel (the “Company”), held an Extraordinary General Meeting of Shareholders of the Company (the “Meeting”). At the Meeting, the shareholders voted on and approved (among other things) a proposal to change the Company’s name to “Enlivex Ltd.” or to such other name containing the word “Enlivex” as may be determined by the Company’s management and approved by the Israeli Registrar of Companies. On February 10, 2026, the Registrar of Companies in Israel issued a Certificate of Change of Name effecting the Company’s name change to Enlivex Ltd. (the “Certificate”). A complete copy of the Certificate is filed as Exhibit 99.1 to this Report on Form 6-K and incorporated herein by reference.
The information contained in this Report on Form 6-K, including Exhibit 99.1, is hereby incorporated by reference into the Company’s registration statements on Forms S-8, F-3 and F-3MEF (File No. 333-256799, File No. 333-232413, File No. 333-232009, File No. 333-252926, File No. 333-286956 and File No. 333-292417), filed with the U.S. Securities and Exchange Commission.
| Exhibit No. | |
| 99.1 | Certificate of Change of Name, filed with the Registrar of Companies in Israel on February 10, 2026. |
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Enlivex Ltd. | ||
| (Registrant) | ||
| By: | /s/ Oren Hershkovitz | |
|
Name: Title: |
Oren Hershkovitz Chief Executive Officer | |
Date: February 23, 2026
2
Exhibit 99.1
CERTIFICATE OF CHANGE OF NAME This is to certify that the company: Company Number: 514716489 Changed its name in Israel according to Companies Laws in the State of Israel, and beginning of 10TH FEBRUARY 2026 it will be called: Shuli Avni-Shoham, Adv. Registrar of Companies Head of the Israeli Corporations Authority PRODUCED ON 10TH FEBRUARY 2026 AT 17:00 To obtain a company information summary, scan the barcode or click here Produced on 10 th February 2026 At 17:00 ୭ " ୬ஂ ୩୰ ୪ " ୳ 10 / 02 / 2026 ୩ୱ୭୵ ୬୭୬ 17:00 ୩୬ To obtain a company information summary, scan the barcode or click here , ஂ୶ୱஂ ୶ୱ୫ ୴ ୬୯୩୬ - ୴୬ஂ ୯ ୯୩୬ ୱ ୴୭ ୨ஂ ୬୩୭୫ ୨୭ ୴୴୯୭ ୳୨୷ ୵ ୱ୭ୱ ஂ୭୫ஂ CERTIFICATE OF CHANGE OF NAME : ୬୯୩୬ ୳ୱ ୴ஂ୭୫୬ ୭୮୨ஂ This is to certify that the company: ୶ " ୩ ஂୱ୭୰ୱ ୨୴ୱୱ୩ ENLIVEX THERAPEUTICS LTD Company Number: 514716489 : ୯୩୬ ୶ Changed its name in Israel according to Companies Laws in the State of Israel, and beginning of 10 th February 2026 it will be called: ୩ୱ୨୴ ୶୬ ୨ஂ ୱஂ୬ , ୱ୨୴ ୩୶୫ୱஂ ୬୯୩୭ஂ ୫ୱୱ ୴ୱ ୭ " ୬ஂ ୩୰ ୪ " ୳ , 10 / 02 / 2026 ୶ୱ୭୵ ୭୬୯୴ : ୩୵ ஂୱ୨ ୶ " ୩ ୨୴ୱୱ୩ ENLIVEX LTD Shuli Avni - Shoham, Adv. Registrar of Companies Head of the Israeli Corporations Authority ୫ " ୭ , ୭୬୵ - ୨୩ୱ ୭୴ୱ ୬୯୩୭ஂ ୶ஂ ୬ஂ୨୪ୱ୫ୱ୵ ୭ஂ ୨